Little Green Pharma Ltd
Little Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. The company offers dried cannabis flower medicines and cannabis oils. Little Green Pharma Ltd was incorporated in 2016 and is based in West Perth, Australia.
Little Green Pharma Ltd (LGP) - Total Assets
Latest total assets as of September 2025: AU$97.60 Million AUD
Based on the latest financial reports, Little Green Pharma Ltd (LGP) holds total assets worth AU$97.60 Million AUD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Little Green Pharma Ltd - Total Assets Trend (2017–2025)
This chart illustrates how Little Green Pharma Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Little Green Pharma Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Little Green Pharma Ltd's total assets of AU$97.60 Million consist of 23.6% current assets and 76.4% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$2.38 Million | 2.5% |
| Accounts Receivable | AU$3.96 Million | 4.1% |
| Inventory | AU$13.83 Million | 14.4% |
| Property, Plant & Equipment | AU$60.30 Million | 62.7% |
| Intangible Assets | AU$3.36 Million | 3.5% |
| Goodwill | AU$856.00K | 0.9% |
Asset Composition Trend (2017–2025)
This chart illustrates how Little Green Pharma Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Little Green Pharma Ltd's current assets represent 23.6% of total assets in 2025, a decrease from 84.6% in 2017.
- Cash Position: Cash and equivalents constituted 2.5% of total assets in 2025, down from 75.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 2.0% in 2017.
- Asset Diversification: The largest asset category is property, plant & equipment at 62.7% of total assets.
Little Green Pharma Ltd Competitors by Total Assets
Key competitors of Little Green Pharma Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Little Green Pharma Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Little Green Pharma Ltd generates 0.38x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Little Green Pharma Ltd generates $ 3.46 in net profit.
Little Green Pharma Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.19 | 2.64 | 2.37 |
| Quick Ratio | 0.87 | 1.01 | 1.86 |
| Cash Ratio | 0.30 | 0.61 | 0.00 |
| Working Capital | AU$16.63 Million | AU$ 13.01 Million | AU$ 909.55K |
Little Green Pharma Ltd - Advanced Valuation Insights
This section examines the relationship between Little Green Pharma Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.44 |
| Latest Market Cap to Assets Ratio | 0.15 |
| Asset Growth Rate (YoY) | 11.3% |
| Total Assets | AU$96.12 Million |
| Market Capitalization | $14.26 Million USD |
Valuation Analysis
Below Book Valuation: The market values Little Green Pharma Ltd's assets below their book value (0.15 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Little Green Pharma Ltd's assets grew by 11.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Little Green Pharma Ltd (2017–2025)
The table below shows the annual total assets of Little Green Pharma Ltd from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$96.12 Million | +11.28% |
| 2024-06-30 | AU$86.38 Million | -12.41% |
| 2023-06-30 | AU$98.62 Million | +2.79% |
| 2022-06-30 | AU$95.95 Million | -13.56% |
| 2021-06-30 | AU$110.99 Million | +576.58% |
| 2020-06-30 | AU$16.40 Million | +5.39% |
| 2019-06-30 | AU$15.57 Million | +287.07% |
| 2018-06-30 | AU$4.02 Million | +315.13% |
| 2017-06-30 | AU$968.73K | -- |